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Abstract 
Respiratory complex I (NADH:ubiquinone oxidoreductase), one of the largest membrane-
bound enzymes in mammalian cells, powers ATP synthesis by using the energy from electron 
transfer from NADH to ubiquinone-10 to drive protons across the energy-transducing 
mitochondrial inner membrane. Ubiquinone-10 is extremely hydrophobic, but in complex I 
the binding site for its redox-active quinone headgroup is ~20 Å above the membrane surface. 
Structural data suggest it accesses the site by a narrow channel long enough to accommodate 
almost all its ~50 Å isoprenoid chain. However, how ubiquinone/ol exchange occurs on 
catalytically-relevant timescales, and whether binding/dissociation events are involved in 
coupling electron transfer to proton translocation, are unknown. Here, we use 
proteoliposomes containing complex I, together with a quinol oxidase, to determine the 
kinetics of complex I catalysis with ubiquinones of varying isoprenoid chain length, from 1 to 
10 units. We interpret our results using structural data, which show the hydrophobic channel 
is interrupted by a highly-charged region at isoprenoids 4 to 7. We demonstrate that 
ubiquinol-10 dissociation is not rate determining, and deduce that ubiquinone-10 has both the 
highest binding affinity and the fastest binding rate. We propose that the charged region and 
chain directionality assist product dissociation, and that isoprenoid stepping ensures short 
transit times. These properties of the channel do not benefit the exhange of short-chain 
quinones, for which product dissociation may become rate limiting. Thus, we discuss how the 
long channel does not hinder catalysis under physiological conditions, and the possible roles 
of ubiquinone/ubiquinol binding/dissociation in energy conversion. 
 
Significance statement  
Respiratory complex I, a redox-coupled proton pumping enzyme, is central to aerobic 
metabolism in mammalian mitochondria, and implicated in many neuromuscular disorders. 
One of its substrates, ubiquinone-10, binds in an unusually long and narrow channel, which is 
at the intersection of the enzyme’s electron and proton transfer modules and a hotspot for 
disease-causing mutations. Here, we use a minimal, self-assembled respiratory chain to study 
complex I catalyzing with ubiquinones of different isoprenoid chain lengths. We show that 
the channel enhances the affinity of long-chain quinones, assists in their transfer along the 
channel, and organizes them for product release. Finally, we discuss how efficient binding 
and dissociation processes may help to link redox catalysis to proton pumping for energy 
conversion. 
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/body Introduction 
 
Respiratory complex I (NADH:ubiquinone oxidoreductase) (1) is a major entry point to the 
electron transport chain of oxidative phosphorylation in mammalian mitochondria. It 
catalyzes NADH oxidation coupled to ubiquinone reduction, and captures the free energy 
produced to transport protons (2, 3) across the mitochondrial inner membrane, supporting 
ATP synthesis and transport processes. Because complex I is essential for regenerating NAD+ 
to sustain the tricarboxylic acid cycle and fatty acid oxidation, and an important contributor to 
cellular reactive oxygen species production (4), mutations in its subunits and assembly factors 
cause a wide range of inherited neuromuscular and metabolic diseases (5). 
 Mammalian complex I is a large (1 MDa) membrane-bound enzyme of 45 subunits. 
Due to advances in single-particle electron cryo-microscopy (cryoEM), knowledge of its 
structure (6–8) has surged forward recently, and descriptions of the 14 core subunits, in 
mammalian (6–8), fungal (9) and bacterial (10) enzymes, have laid a new foundation for 
mechanistic studies. NADH is oxidized by a flavin near the top of the hydrophilic domain of 
the L-shaped complex. Then, electrons are transferred along a chain of seven iron-sulfur (FeS) 
clusters to ubiquinone, bound at the interface of the hydrophilic and membrane domains. The 
membrane domain contains four antiporter-like units, considered to each transport one proton 
per cycle. They are connected by elements indicative of ion-transport activities, including p-
bulges, loops in transmembrane helices (TMHs), and a series of buried charged residues, 
which also connects them to the quinone-binding region. Although molecular simulations 
have suggested how conformational, protonation, and hydration changes could propagate 
through the membrane domain to drive proton transfer events (11), how the energy from 
quinone reduction is captured and transferred to proton translocation is currently unknown. 
Reactions that may initiate the proton-transfer cascade include movement of a conserved 
aspartate upon quinone reduction (12), double reduction of Q to Q2− or its subsequent 
protonation to QH2 (13), and/or quinone binding/quinol dissociation. It has also been 
suggested that a permenantly-bound quinone shuttles between two positions in the channel, 
requiring an additional site for the exchangeable substrate to bind (14). 
Here, we focus on ubiquinone binding and reduction by mammalian complex I. 
Strikingly, the binding site for the redox-active ubiquinone headgroup is ~20 Å above the 
membrane interface, and thought to be accessed by a long, narrow channel (Figure 1) that has 
been identified in all the structures described so far, but not yet confirmed experimentally. 
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The headgroup binds in a cleft between the 49 kDa and PSST subunits [we use the 
nomenclature for the bovine enzyme throughout] and both mutational studies in Yarrowia 
lipolytica (15) and Escherichia coli (16), and densities observed in structural data from 
Thermus thermophilus complex I (10), indicate that it forms hydrogen bonds with H5949kDa 
and Y10849kDa, placing it within 12 Å of the terminal FeS cluster, N2. At the base of the cleft, 
the predicted channel meets subunit ND1, and runs along its interface with the 49 kDa and 
PSST subunits before exiting into the membrane; in total, it is long enough to accommodate 
most of the ~50 Å long isoprenoid tail of ubiquinone-10. Many structurally diverse inhibitors 
are thought to bind in the channel (17) and it is a hotspot for both pathophysiological 
mutations (5, 18) and site-directed variants that affect catalysis (19, 20). 
Here, we have used proteoliposomes (PLs) to determine the kinetics of complex I 
catalysis with a series of ubiquinone substrates of varying isoprenoid tail length, from 
ubiquinone-1 (Q1) to ubiquinone-10 (Q10). Previous attempts to investigate the effects of 
quinone tail length used native membranes supplemented with exogenous quinones, following 
removal of the endogenous Q10 by lyophilization and pentane extraction (21–23). However, 
these studies were compromised because i) the quinone exchange procedures were 
detrimental to catalysis (the specific activities were 10-fold lower than observed here) and ii) 
effects on complex I activity were obscured by the catalysis of other enzymes: Lenaz et al. 
(23) reconstituted Q1 to Q10 into lyophilized pentane-extracted mitochondria and measured 
O2 consumption, which requires complexes III and IV, whereas Estornell et al. (21) similarly 
reconstituted Q10 and measured cytochrome c reduction, which requires complex III. More 
recently, Fato et al. (22) assayed lyophilized pentane-extracted bovine mitochondria 
reconstituted with Q3, Q5 and Q10 with an NADH-Q1 reductase assay. In contrast, our PLs 
(24) contain highly active bovine complex I (CI, to oxidize NADH and reduce ubiquinone to 
ubiquinol), the cyanide-insensitive non-protonmotive alternative oxidase from Trypanosoma 
brucei brucei (AOX, to reoxidize ubiquinol to ubiquinone and reduce O2) and varying 
concentrations of different ubiquinones. The system and its kinetic properties can be defined 
precisely through measurements of the protein, phospholipid and ubiquinone contents, and 
have been developed to ensure complex I is rate determining. We compare the kinetic 
parameters of different ubiquinones with the structural and physico-chemical properties of the 
quinone-binding channel to reveal new determinants of catalysis. 
 
Results 
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Ubiquinone reduction by complex I is rate limiting for catalysis 
The CI-AOX PLs described here catalyze NADH:O2 oxidoreduction (the NADH:O2 reaction) 
by redox cycling ubiquinone/ubiquinol: complex I reduces ubiquinone to ubiquinol and AOX 
reoxidizes it. To use the NADH:O2 reaction to investigate ubiquinone reduction by complex I 
it must be rate limiting. Thus, the NADH (200 µM) and O2 (200-250 µM) concentrations used 
are substantially higher than the KM values of 79 ± 8 µM for complex I (measured  with the 
NADH:O2 reaction) and 10-20 µM for AOX (25). Furthermore, the kcat value for NADH 
oxidation by the flavin in bovine complex I is >5000 s-1 (26), more than ten times faster than 
the maximum rate of NADH:ubiquinone oxidoreduction, so NADH oxidation does not limit 
catalysis. 
The complex I and AOX used here display similar turnover rates in solution assays 
with ubiquinone-1, typically 250-300 s-1 and 200-250 s-1, respectively. Thus, to increase the 
rate of ubiquinol oxidation, PLs were created starting from a molar ratio of 1:25 CI:AOX. The 
ratio then effectively doubles to 1:46 ± 1.1 (mean value ± S.D. for all samples) because 
NADH can only access complex I oriented with its active site outwards (77 ± 10% of the 
total) whereas AOX substrates can access it in both orientations, and because AOX 
incorporates into PLs more efficiently than complex I (80 ± 15% and 59 ± 11%, respectively). 
This high ratio provides a strong expectation for complex I being rate limiting, and thus for 
the ubiquinone/ol pool being predominantly oxidized during catalysis (24). To test this 
expectation, titrations on the NADH:O2 reaction by Q10-containing PLs with a high (1:51) or 
low (1:1.5) CI:AOX ratio (defined for outward facing complex I) were performed with 
complex I (piericidin A) and AOX (colletochlorin B (27)) specific inhibitors. For both ratios, 
piericidin A inhibition builds rapidly at low concentrations (Figure 2A) and the IC50 values 
are similar (2.0 ± 1.1 and 3.4 ± 1.1 nM, or 8.7 and 8.0 piericidin A per oriented complex I, 
respectively). In contrast, the high ratio PLs were unresponsive to low colletochlorin B 
concentrations (Figure 2B) and displayed an IC50 value 30 times greater (15.9 ± 0.03 and 0.52 
± 0.03 nM, respectively, or 0.7 and 1.4 colletochlorin B per AOX). Thus, in the high ratio 
(typical) preparation most of the AOX can be inhibited with little effect on catalysis, 
confirming that AOX is not rate limiting. High ratio PLs containing Q8, Q6, and Q4, or tested 
with Q2, all gave colletochlorin B IC50 values of 17.6 ± 1.3 nM, matching that for Q10. Only 
for Q1 was the IC50 value for colletochlorin B different; its much higher value of ~5 µM 
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suggests colletochlorin B is a poor inhibitor of ubiquinol-1 oxidation by AOX, or that Q1 is a 
poor complex I substrate.  
 
Measurement of KM and kcat values 
Figure 3 shows Michaelis-Menten curves for complex I catalyzing with Q10, Q8, Q6, Q4, Q2, 
and Q1. The highly hydrophobic Q10, Q8, Q6 and Q4 molecules (calculated logP values 
(cyclohexane/water) 19.4, 15.7, 12, 8.3, respectively (28)) were incorporated into the PL 
membranes during reconstitution so each point is from a different preparation. The samples 
for each curve were prepared together in batches, then their quinone, phospholipid, complex I 
and AOX concentrations determined. Quinone concentrations in the membrane were 
calculated by assuming 1 mg of phospholipid occupies ~1 µL (29), so 1 nmol of quinone per 
mg phospholipid is equivalent to 1 mM. The more hydrophilic Q2 and Q1 molecules were 
added from ethanolic stock solutions to quinone-free PLs and considered to partition between 
the aqueous and membrane phases. Their membrane concentrations were calculated from the 
phase volumes and membrane/water logP values, 4.0 for Q2 and 2.9 for Q1 (30). Micelle 
formation was not considered because the critical micelle concentration of Q2 of 14.0 µM 
(31) is above the maximum 10 µM concentration added, and it was confirmed that all the Q2 
added could be reduced by complex I. Addition of protonophore uncouplers such as 
gramicidin did not increase the rate so they were not included. Finally, to account for 
variations in enzyme activity between the quinone-specific batch preparations, two further 
batches containing samples from each different quinone were prepared (see red and blue 
points in Figure 3); the Q1 and Q2 datasets are from quinone-free PLs included in these 
batches. The Q10 KM dataset was used as the reference and scaling parameters for the other 
datasets derived by simultaneous non-linear least squares fitting; the scaling parameters were 
applied uniformly and so affect only Vmax, not KM. 
 
Dependence of KM and Vmax on isoprenoid chain length 
The KM and Vmax values for each ubiquinone (from Figure 3) are summarized in Figure 4. 
Figure 4A shows that Vmax (or kcat) is biphasic and averages to 23 ± 2 µmol min-1 mg-1 (380 s-
1) for Q10, Q8, Q6 and Q4, and 9.3 ± 0.9 µmol min-1 mg-1 (150 s-1) for Q2 and Q1. Previous 
studies, using pentane-extracted mitochondria, also observed the highest NADH:O2 activities 
from Q7 to Q10, with Q1 to Q4 only supporting ~30% of the Q10 value (22, 23). Figure 4B 
shows that KM displays a bell-shaped curve with the highest value at Q4. We note that the 
Q10 KM value reported here of 0.48 mM is lower than that of 3.9 mM we measured 
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previously (24) due to i) improvements to the AOX preparation that have increased its 
specific activity 2-3 fold; ii) improvements to our quinone quantification protocol; iii) the 
omission of alamethicin. Alamethicin was used previously (24) to open pores in the 
membrane to allow NADH to access all the complex I, but we have now found that 11.25 µg 
mL-1 increases the apparent Q10 KM value from 0.5 ± 0.1 to 1.3 ± 0.4 mM. Alamethicin has 
been reported to sequester membrane-bound fatty acids (32) so may sequester quinones also, 
and to induce structural changes in the membrane (33). Finally, Figure 4C shows that the 
catalytic efficiency or pseudo second order rate constant, kcat/KM, increases markedly for Q8 
and Q10. Previously, kcat/KM was reported to exhibit a bell-shaped dependence on substrate 
hydrophobicity (34) but the earlier study only used quinones with alkyl chains up to 11 
carbons long, whereas the same trend is not replicated here using polyisoprenoid ubiquinones 
with partition coefficients that vary much more.  
 
Analysis of structural data and docking of Q10 
In order to investigate how our data correlate with structural features in complex I, we used 
the Caver software (35) to detect and compare the proposed quinone-binding sites in available 
structures. Figure S1 shows that the bovine (6), porcine (7), T. thermophilus (10), and Y. 
lipolytica (9) structures describe a common channel. The same channel is truncated in the 
ovine structure (8) by the 49 kDa subunit b1-b2 loop, and similarly constricted in the Y. 
lipolytica structure (9). Variations in the channels may arise from their medium resolutions 
and/or different enzyme states; both the ovine and Y. lipolytica enzymes were proposed to be 
in the ‘deactive’ state (8, 9) that is unable to reduce quinone, whereas the cryoEM data set for 
the bovine structure (6) was classified into three states and only the structure allocated to the 
‘active’ state used here. The bovine, porcine and T. thermophilus channels are overlaid in 
Figure 1, highlighting their similarity. 
To better define how quinones bind in the channel, we modeled Q10 into the channel 
identified in the bovine complex (PDB ID: 5LC5 (6)) and relaxed the system by atomistic 
molecular dynamics (MD) simulations (Figure 5A). Subsequently, by truncating the relaxed 
Q10 model, we performed further MD simulations for Q8, Q6, Q4, Q2, and Q1 (Figure 5B). 
Analyses of the Q10-bound structure showed that its channel closely matches the original 
channel (Figure S1) and, in all cases, the modeled protein structures around the bound 
quinones remain in similar conformations except that, for Q1 to Q6 and the empty site, the 
sidechain of F224ND1 moves into the position of isoprenoid-7 (Figure S2A). Notably, the root-
mean-square fluctuations (RMSFs) of the bound quinone variants suggest that the long 
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isoprenoid chains of Q8 and Q6, which overlay closely on that of Q10 (Figure 5B), are 
spatially tightly constrained by the channel, whereas the shorter chains of Q4, Q2 and Q1 
have much greater conformational freedom (Figure 5C). 
Strikingly, Figure 6 shows how the properties of residues close to the modeled Q10 
vary along it (Figure S3 presents equivalent data for Q8 to Q1). The environment of the 
headgroup plus isoprenoids 1 to 3, in the cleft between the PSST and 49 kDa subunits, is 
primarily hydrophobic and uncharged. Conversely, that of isoprenoids 4 to 7 contains many 
charged residues. In particular, a group of highly conserved arginines (Figure 5A) form an 
channel elbow that produces a ~100° kink in the modeled Q10 between isoprenoids 4 and 5. 
Notably, the hydrophobic faces of the Arg guanidiniums form p-stacking interactions with the 
isoprenoids, while their edges form polar and electrostatic interactions with a set of conserved 
Glu/Asp residues (Figure 5A), consistent with the known behavior of guanidium groups (36). 
In the modeled structures, interactions between the charged residues separate them into two 
groups (Figure S2B), with the group involving residues on ND1 TMH1 showing less 
positional variation than that involving primarily residues on the ND1 TMH5-6 loop (Figure 
S2C), noted previously for its flexibility (6). Finally, for isoprenoids 8 and 9 the expected 
hydrophobic nature of the ubiquinone-binding channel is re-established. 
 
Discussion 
 
Entry and exit of quinone/quinol to and from the channel 
In the classical Michaelis-Menten model, kcat encapsulates all the steps that follow formation 
of the enzyme-substrate complex, so the fact that kcat is constant for Q4 to Q10 (Figure 4A) 
suggests that product dissociation, which is expected to be chain-length dependent, is not rate 
limiting. Alternative rate-limiting steps include the electron-proton transfers for quinone 
reduction, the coupled processes leading to proton translocation, and all the reactions required 
to complete the catalytic cycle. 
 For Q2 and Q1, kcat (150 s-1) is substantially lower than for Q4 to Q10 (380 s-1) (Figure 
4A) so the rate-limiting step has either slowed or changed identity. Both possibilities indicate 
that a chain-length dependent step, such as product dissociation, has slowed down. 
Furthermore, the pseudo second-order rate constant kcat/KM (where KM = (koff + kcat)/kon) 
provides a guide to the rate constant for substrate binding (kon) since it approximates to it 
when kcat > koff and reflects how fast the rate increases with increasing concentration, in 
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substrate-limiting conditions. kcat/KM increases substantially with isoprenoid-tail length 
(Figure 4C). Both observations are consistent with rates of binding and dissociation (i.e. 
channel transit rates) increasing with isoprenoid chain length, and being limiting only for Q2 
and Q1. We propose three explanations. First, the short isoprenoid tails of Q1, Q2 and Q4 do 
not overlay their respective Q10 isoprenoids (Figure 5B) so they are conformationally mobile 
within the site (Figure 5C): their dissociation may be hindered by lack of directionality, due to 
lack of a guiding anchor extending down the channel. The tail of Q10 extends into the 
membrane and may guide the entire dissociation process. Second, for the shorter quinones an 
additional molecule(s) may enter the channel behind the substrate, impeding its dissociation. 
Third, the channel entrance is at a similar depth below the membrane interface to the favored 
position for the ubiquinone-10 headgroup (37), whereas shorter-tail quinones may distribute 
differently in the membrane, affecting their binding rates. 
 Finally, while the simple Michaelis-Menten mechanism provides a convenient 
framework for interpreting our data, it does not account for the unusual nature of the 
ubiquinone-binding channel in complex I. Transfer along the whole channel is unlikely to 
occur over a single transition state but over a complex energy surface that may form local 
minima and transient binding sites. Longer chains species may move faster along the channel 
because their stepwise movements incur minimal changes. For example, moving a Q10 
molecule by one step requires only the residues (and water molecules) around the headgroup 
and the leading isoprenoid to reorganize (at all other positions one isoprenoid simply replaces 
another), whereas moving a short chain quinone reguires the region behind it to reorganize 
also. The energy surface for Q10 transit along the channel may therefore be flatter. In this 
way, the unusually long substrate-binding channel in complex I need not exert a rate limiting 
effect on catalysis. 
 
Effect of isoprenoid chain length on binding affinity 
In classical Michaelis-Menten kinetics, KM is expressed as (koff + kcat)/kon so, for Q4 to Q10, 
where kcat is constant (Figure 4A) but KM decreases with increasing chain length (Figure 4B), 
koff decreases and/or kon increases. Both possibilities suggest that Kd (= koff/kon) decreases, 
such that Q4 binds most weakly and Q6, Q8 and Q10 progressively more tightly. The 
comparison does not extend to Q2 and Q1 because kcat is different, but as their kcat values are 
similar the same considerations suggest Q1 binds more tightly than Q2. Thus, although a 
robust comparison between Q4 and Q2 is currently not possible, we may infer that the curve 
describing Kd qualitatively resembles that of KM. 
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 The relative free energy changes that result from moving each quinone species from a 
low dielectric (membrane) environment into its complex I binding site were evaluated using 
continuum electrostatics calculations (38), revealing a linear dependence on isoprenoid 
number (Figure S4). The trend is consistent with the decreasing Kd proposed for Q4 to Q10, 
but not with the decrease proposed for Q4 to Q1. Intriguingly, the discrepancy can be 
explained by considering that koff for Q4, Q2 and Q1 may be decreased, as discussed above, 
by them lacking a guiding chain for dissociation, and by additional substrate molecules 
blocking their exit. By decreasing koff these factors ‘cage’ short chain species in the binding 
site, independently of their intrinsic affinity for it, and decrease Kd. Notably, many tight-
binding hydrophobic complex I inhibitors match the dimensions of Q1 to Q4 and are 
considered to occupy the same binding site; density attributed to piericidin A, which 
resembles Q3, was observed to overlay density attributed to decylubiquinone in 
crystallographic maps from T. thermophilus complex I (10). Thus, the potent inhibition of 
these molecules may also partly result from caging effects. 
 The concept of a highly-charged channel for the hydrophobic isoprenoid chain, as 
observed for isoprenoids 4 to 7 (Figures 5 and 6), is intrinsically challenging. Charged 
cavities in proteins tend to fill with water molecules (39), and indeed, in MD simulations on 
the structure of T. thermophilus complex I, waters accumulate in the channel, especially in the 
charged region (11). If waters are present it may be that i) the channel has become hydrated 
artificially during the extended handling required for structural work, or ii) during every 
catalytic cycle the quinone displaces waters, making an entropic contribution to offset the 
enthalpy loss of breaking charged and polar interactions. In fact, an unfavourable binding 
enthalpy from the charged region may mitigate the increasing affinity due to binding an 
increasing number of hydrophobic units within a hydrophobic channel, and be important for 
efficient product release. Higher resolution structural data is required for further 
understanding of this intriguing structural feature. 
 Finally, increased contributions to the binding affinity from the second, non-polar 
region at isoprenoids 8 and 9 causes a marked increase in kcat/KM (Figure 4C). Because kcat is 
constant from Q4 to Q10, kcat/KM is dominated by the reciprocal of KM and the apparent 
discontinuity in Figure 4C results simply from a point of inflexion in the KM curve. 
 
How is proton translocation coupled to quinone reduction? 
The identity of the coupling point, at which the redox reaction initiates proton translocation, is 
currently the most important unknown feature of the complex I mechanism. Molecular 
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dynamics simulations of the movement of D16049kDa away from H5949kDa, as a result of 
proton transfer from H59 to the nascent quinol, have been used to illustrate one possibility 
(12). Alternatively, could conformational changes triggered by quinone/quinol moving along 
the channel, particularly through the charged section, trigger proton translocation? If so, short 
chain quinones must activate the mechanism as effectively as long chain quinones, since they 
elicit the same proton-pumping stoichiometry (2, 3). As Figure 5A shows, the charged 
residues surrounding the channel are, like D160, connected to the center of the membrane 
domain by a chain of acidic residues (6–10, 12) suggesting how quinone/ol 
binding/dissociation may be communicated to the proton translocation machinery. To 
elucidate, challenge and add to proposals for the mechanistic coupling point in complex I 
requires higher resolution structures set in different states, alongside mutational, functional 
and computational studies to provide complementary strategies and perspectives on tackling 
this difficult problem. 
 
Experimental methods 
 
Preparation of AOX 
The construct described previously for over-expression of AOX from T. brucei brucei (40) 
was modified by removing the N-terminal mitochondrial targeting peptide (residues 1-24) and 
replacing the 6xHis tag with a Twin-Strep® tag (IBA GmbH) (41). The modified AOX was 
over-expressed in E. coli strain FN102 (40) in a 60 L fermenter as described previously (24, 
40), except using 100 µg mL-1 ampicillin instead of carbenicillin. The culture was incubated 
at 30 °C, 60% O2 saturation until OD600 ~0.6, then expression induced with 25 µM isopropyl 
b-D-1-thiogalactopyranoside for 12 hours. Cells (200-300 g) were collected by centrifugation 
then membranes prepared immediately (24) and resuspended to ~30 mg protein mL-1 in 50 
mM Tris-HCl (pH 8.0 at 4 °C) for storage at -80 °C. 
All the following steps were at 4 °C. 20 mL of membranes were solubilized at 6 mg 
protein mL-1 in 25 mM Tris-HCl (pH 8.0 at 4 °C), 200 mM MgSO4, 1.4% (w/v) n-octyl-
glucopyranoside (Anagrade, Anatrace) and 20% (v/v) glycerol for 1 hour then centrifuged 
(165,000 x g, 30 min.). The supernatant was loaded onto a ~8 mL column of Strep-Tactin® 
Superflow® high capacity resin (IBA GmbH) pre-equilibrated in Strep buffer: 20 mM Tris-
HCl (pH 8.0 at 4 °C), 50 mM MgSO4, 160 mM NaCl and 20% (v/v) glycerol (41). AOX was 
eluted in Strep buffer supplemented with 2.5 mM desthiobiotin (Sigma Aldrich) and 0.042% 
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n-dodecyl-b-D-maltopyranoside (DDM) (Anagrade, Anatrace) (41). Pooled AOX-containing 
fractions were concentrated ten-fold, then dialyzed for 6 hours against 2 L of Strep buffer plus 
0.042% DDM (24). Typical preparations yielded 3-5 mg AOX and were ≥95% pure by SDS-
PAGE. 
 
Preparation of complex I 
Mitochondrial membranes were prepared from Bos taurus (bovine) heart (42) then complex I 
prepared as described previously (24), with minor modifications. Membranes were solubilized 
at 5 mg mL-1 protein in 1% DDM. The Q-sepharose buffers consisted of 20 mM Tris-HCl (pH 
7.55 at 4 °C), 2 mM EDTA, 10% (v/v) ethylene glycol, 0.2% (w/v) DDM, 0.02% asolectin 
(total soy lipid extract, Avanti Polar Lipids) and 0.02% 3-[(3-cholamidopropyl)-
dimethylammonio]-1-propanesulfonate (CHAPS). Size exclusion chromatography was 
conducted on a Superose™ 6 Increase 10/300 column (GE Healthcare) in 20 mM Tris-HCl 
(pH 7.55 at 4 °C), 200 mM NaCl, 0.05% DDM and 10% (v/v) glycerol. Samples were flash 
frozen for storage at ~20 mg mL-1 in 30% (v/v) glycerol. 
 
Preparation of CI-AOX PLs 
Chloroform solutions (25 mg mL-1) of bovine heart phosphatidylcholine (PC), 
phosphatidylethanolamine (PE) and cardiolipin (CL) were from Avanti Polar Lipids. 
Chloroform stock solutions of Q10 (Sigma Aldrich), Q8 (Avanti Polar Lipids), Q6 (Avanti 
Polar Lipids) and Q4 (Santa Cruz Biotechnology) were created at 2-4 mM. PLs were prepared 
as described previously (24), starting from mixtures of 8 mg PC, 1 mg PE, 1 mg CL and 
quinone (as required). 
 
Characterization of PLs 
To quanitify the quinone present, 90 µL of ethanol (HPLC grade Chromasolv, Sigma Aldrich) 
was added to 10 µL of PL solution, sonicated (1 min.) and centrifuged (16,300 x g, 10 min.). 
50 µL of supernatant were injected onto a Nucleosil 100-5C18 (Hichrom) column, and run at 
30 °C at 800 µL min-1 on an Agilent 1100 series HPLC in 70% ethanol, 30% methanol, 
0.07% HClO4 and 50 mM NaClO4 for Q10 and Q8, or in 100% methanol, 0.07% HClO4 and 
50 mM NaClO4 for Q6 and Q4 (retention times 9, 6, 10 and 5 min., respectively). 
Concentrations were determined by comparison with known standards. Total phospholipid 
content was determined as detailed previously (24). Total protein contents were quantified by 
the amido black assay, which is insensitive to detergents and high phospholipid 
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concentrations (43). The NADH:APAD+ oxidoreduction assay was used to determine the total 
complex I content and orientation together with 15 µg mL-1 alamethicin to allow NADH into 
the PL lumen (24). The AOX content was taken as the difference between the total protein 
and complex I contents. 
 
Catalytic activity assays 
Activity assays were at 32 °C in 10 mM Tris-SO4 (pH 7.5 at 32 °C), 50 mM KCl, 200 µM 
NADH with ~1.5 mg protein mL-1 PLs (24). NADH oxidation was monitored at 340-380 nm 
(e = 4.81 mM-1 cm-1) on a Molecular Devices Spectramax 384 plus platereader. Q2 and Q1 
(Sigma Aldrich) were added in ethanol. Inhibitor-insensitive rates were determined in 0.5 µM 
piericidin A as 0.30 ± 0.03 µmol NADH min-1 mg CI-1 for all quinones except Q1 (which 
exhibited a concentration-dependent inhibitor-insensitive rate) and have been subtracted from 
the data reported.  
 
Molecular modeling of ubiquinone-bound structures 
Ubiquinone-10 was docked into a channel identified by the HOLE software (44) in the 
structure of bovine complex I (PDB ID: 5LC5) with missing amino acid side chains modelled 
in (6). Then, 20 ns of classical molecular dynamics (MD) simulation (integration time step 2 
fs, 310 K) were performed using NAMD2 (45) with the CHARMM36 force field (46), and 
DFT-derived parameters for all cofactors (12). Backbone atoms of the 49 kDa, ND1, and 
PSST subunits were harmonically restrained (force constant 2 kcal mol-1 Å-2), with positional 
constraints for all other subunits. The A57-V61 and L106-S110 loops of the 49 kDa subunit 
that carry H59 and Y108 were not restrained. For the Q1-Q8 bound structures, the Q10 
molecule was truncated and each variant relaxed for a further 10 ns. Free energies for quinone 
solvation into complex I were estimated by the MM-GBSA method (38), using 50 snapshots 
extracted from 10 ns MD simulations. The modeled structures with Q1 to Q10 bound and 
with the empty site are available from the University of Cambridge data repository 
(https://doi.org/10.xxxxx/CAM.xxxxx). 
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Figure Legends 
 
1. The proposed ubiquinone-binding channel in mammalian complex I. The 49 kDa, 
PSST and ND1 subunits from bovine complex I (5LC5.pdb (6)) are in cartoon, with the 
surfaces of predicted quinone-binding cavities in the aligned structures of the bovine (6) 
(cyan), porcine (7) (yellow) and T. thermophilus (10) (purple) enzymes. The quinone 
headgroup is considered to hydrogen bond to Y108 and H59, and H59 to D160. The 
carboxylate groups of acidic residues connecting the quinone-binding region to the proton 
pumping subunits are shown by red spheres. Cavities were generated using the Caver 3.0 
PyMOL plugin (35) with a 1.4 Å probe. 
 
2. Complex I is rate limiting for catalysis in CI-AOX PLs. Normalized rates of the 
NADH:O2 reaction by PLs containing high (1:51, blue) and low (1:1.5, red) ratios of oriented-
CI:AOX are shown. Both preparations contained ~10 mM Q10. A) Inhibition by piericidin A. 
B) Inhibition by colletochlorin B. 
 
3. Michaelis-Menten curves for reduction of Q1 to Q10 by complex I. The black points are 
from sets of PLs with different quinone concentrations; the datasets for Q1 to Q8 were 
adjusted to the Q10 dataset using the red and blue datasets and scaling factors of 1.44 (Q8), 
1.35 (Q6), 1.86 (Q4), 1.57 (red points), 1.60 (blue points). Each value is the mean of at least 
three replicates ± the standard deviation propagated from each underlying measurement. 
 
4. Dependence of the Michaelis-Menten parameters on isoprenoid chain length. (A) Vmax 
and kcat values shown with average values of 9.3 ± 0.9 µmol min-1 mg-1 (150 ± 15 s-1) for Q1 
to Q2 and 23 ± 2 µmol min-1 mg-1 (380 ± 39 s-1) for Q4 to Q10. (B) KM values; the curve is 
only to guide the eye. (C) kcat/KM values with two linear fits (gradients 7.0 and 220 mM-1 s-1 
isoprenoid unit-1). Values are from the data in Figure 3 and also given in Table S1. 
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5. Modeled structures of bovine complex I with Q1 to Q10 bound. A) The modeled Q10 
molecule with its isoprenoids in black and cyan alternately, alongside the sidechains of 
charged residues within 5 Å (red, PSST; blue, ND1). Green: 49 kDa subunit residues 
hydrogen bonded to the ubiquinone headgroup. B) The overlaid modelled structures for Q10, 
Q8, Q6 and Q4, and (inset) for Q10, Q4, Q2 and Q1. C) RMSFs for each quinone species 
from MD simulations, colored as in B. 
 
6. The protein environment of the modeled bound Q10 molecule in the structure of 
bovine CI. A) Percentage of residues within 5 Å of each isoprenoid that are hydrophobic (A, 
F, I, L, M, P, V, W, Y) or hydrophilic (C, D, E, G, H, K, N, Q, R, S, T). B) Percentage of 
residues within 5 Å of each isoprenoid that are canonically charged (D, E, H, K, R), and that 
are arginines. 
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Supplementary Table 1: Fitting parameters for the data in Figure 3 
 
 KM (mM) 
Vmax 
(µmol min-1 mg-1) 
kcat 
(s-1) 
kcat/KM 
(mM-1 s-1) R
2 
Q1 4.1 ± 0.95  10.2 ± 0.69 168 ± 11 41 ± 9.8 0.9575 
Q2 8 ± 3.1 8.4 ± 0.41 138 ± 6.9  17 ± 6.2 0.8500 
Q4 10 ± 2.8 27 ± 2.7 439 ± 44 42 ± 12 0.9615 
Q6 5.4 ± 0.94 22 ± 1.2 363 ± 20 66 ± 12 0.9787 
Q8 1.0 ± 0.23 20.1 ± 0.93 332 ± 15 319 ± 71 0.9591 
Q10 0.49 ± 0.081  22.5 ± 0.58 371 ± 9.5 764 ± 130 0.9771 
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S1. Predicted quinone-binding cavities in published complex I structures. A) The active 
state of bovine complex I (PDB ID: 5LC5) (6). B) The bovine structure with Q10 modeled in 
using MD simulations (Q10 was removed for the channel prediction). C) Complex I from the 
porcine respirasome (PDB ID: 5GUP) (7). D) T. thermophilus complex I (PDB ID: 4HEA) 
(10). (E) Y. lipolytica complex I (PDB ID: 4WZ7) (9). F) Ovine complex I (PDB ID: 5LNK) 
(8) in which the cavity is blocked by the β1-β249kDa loop; the cavity from panel A is overlaid 
as a mesh for comparison. G) The active state of bovine complex I (PDB ID: 5LC5) with the 
modeled Q10 structure overlaid. H) The bovine structure with Q10 modeled in using MD 
simulations. Cluster N2 is shown as spheres and Y10849kDa is shown because its hydroxyl 
oxygen was used as the starting point for cavity searches. Channels were predicted using the 
Caver 3.0 plugin in PyMOL (35) with a probe size of 1.4 Å or 1.1 Å for panel E. 
 
S2. Conformational changes in the modeled ubiquinone-bound states. A) The sidechain 
of F224ND1 responds to the isoprenoid chain in energy-minimized structures with different 
species bound. For Q1 to Q6 and the ubiquinone-free state, it obstructs the channel at 
isoprenoid 7, whereas for Q8 and Q10 it has moved away. Also shown are variations in the 
positions of the sidechains of Y108 and H59 in the presence and absence of the ubiquinone 
headgroup. B) The charged residues within 5 Å of isoprenoids 4 to 7 form two distinct groups 
of interacting residues. Predicted hydrogen bonds are shown with dashed yellow lines. C) The 
sidechains in the right-hand set (including residues on a nearby helix) show less variation in 
their positions between the different states than those in the left-hand set that are 
predominantly present on loops. 
 
S3. Comparison of the protein environments of quinone molecules with different 
isoprenoid chain lengths in modeled structures. A) The percentage of residues within 5 Å 
of each isoprenoid unit that are classified as hydrophobic (A, F, I, L, M, P, V, W, Y). B). The 
percentage of residues within 5 Å of each isoprenoid unit that are classified as hydrophilic (C, 
D, E, G, H, K, N, Q, R, S, T). C) The percentage of residues within 5 Å of each isoprenoid 
unit that are canonically charged (D, E, H, K, R). D) The percentage of residues within 5 Å of 
each isoprenoid unit that are arginine. 
 
S4. Estimated relative free energies for solvation of quinone in the complex I binding site 
for each quinone variant. The free energies of solvation were estimated using continuum 
electrostatics calculations on 50 snapshots extracted from the MD simulations, by the MM-
  2 
GBSA method (38). The calculation provides a free energy change relative to quinone in a 
reference medium, here the low dielectric membrane slab. All values are given relative to the 
value for Q1. Although this simplified MM-GBSA model accounts for electrostatic solvation 
free energies, it does not account for entropic contributions. A complete treatment would 
require computationally-demanding free energy calculations that are not currently justified by 
the resolution of available structural data. 
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